WACPtv IS SWITCHING TRACKS .. CLICK HERE!......STAY TUNED FOR THE BEST AND THE REST OF YOUR LIFE... IT BECAME TOO EXPENSIVE TO STAY ON THIS TRAIN.............. ENJOY YOUR NEW FREE RIDE!
101FOOD I 202COM303CRAF404EDU505ENGINE I606FASHN707HEALTH I808PERF909 ESTATE110MONEY111REFORM I112GRAPHIC

        MOVIES & MUZIC                  I                  WOW - MUST WATCH!               I               ALT DIRECTORY               I                  NEW OPPORTUNITIES

September 23, 2014
Written by: Austin Kirk

As discovery continues in the federal Lipitor litigation involving lawsuits brought by women who allege the popular cholesterol drug caused them to develop type II diabetes, the U.S. District Judge presiding over the cases has indicated that the first bellwether trial will begin in October 2015.

There are currently more than 1,250 product liability lawsuits pending against Pfizer in the federal court system, which all involve similar allegations that side effects of Lipitor caused diabetes for women taking the medication as a preventative measure to reduce their cholesterol levels and reduce the risk of heart disease.

The cases are consolidated for pretrial proceedings as part of an MDL, or Multidistrict Litigation, which is centralized before U.S. District Judge Richard Gergel in the District of South Carolina to reduce duplicative discovery among the cases, avoid conflicting pretrial rulings and to serve the convenience of the parties, witnesses and the courts.

According to minutes posted to the court’s docket following a status conference on Friday, a Lipitor diabetes case will go before a federal jury in October 2015, serving as a “bellwether” trial to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation.
Lipitor Bellwether Trials

As part of the coordinated litigation before Judge Gergel, a small number of lawsuits have been identified as bellwether cases, going through case-specific discovery in preparation for this first trial date. A prior case management order indicated that the Lipitor bellwether cases must be trial-ready by July 2015.

The current pool of 12 “initial discovery” cases are expected to be reduced to a group of six in December, with each side identifying three cases that will be eligible for the first trial. Judge Gergel has indicated that he will then randomly select one of the remaining cases later this year to go forward for the first trial, which is now expected to begin in October 2015.

In a new case management order (PDF) issued on September 22, Judge Gergel addressed several on-going discovery issues in the litigation, imposing limitations on the ability of the parties to meet independently with plaintiffs’ treating physicians.

Defense counsel has been ordered not to meet “ex parte” with treating or prescribing healthcare providers, unless they have permission of plaintiffs’ counsel. Plaintiff’s counsel may meet independently with the physicians, but must disclose if certain records or documents are discussed with the treaters.

Although the outcome of bellwether trials are not binding on other lawsuits, the cases are being closely monitored by attorneys involved in the litigation, as they may influence any eventual Lipitor settlement negotiations.
- See more at: http://www.aboutlawsuits.com/lipitor-diabetes-lawsuit-trial-date-71...

Views: 12

Reply to This

1.0 SPACEBOOK ALMANAC. The MULTI-MEDIA INTERACTIVE AGGREGATE OF CATEGORIZED CONSCIOUS CREATIVE CONTENT & ACTIONS IN REAL-TIME..JOIN US NOW!

CONNECTIONS

 GBI  UIN U2bCh  Share |

WE ARE THE DIVINE SOLUTIONS TO THE WORLD....LET OUR TRUE SPIRIT BE REVEALED TO THE WORLD!

RSS

Why a faecal transplant could save your life

Patient's lives are being saved by poo, but how far can microbial medicine go?

Allied Healthcare: Home care provider seeks rescue plan

Allied Healthcare, one of the UK's biggest providers of in-home care, blames a "challenging environment".

Cystic fibrosis: Company urged to lower cost of life-changing drug

Health ministers call on company to lower price of cystic fibrosis drug Orkambi so the NHS can afford it.

Is marathon running bad for you?

Some 40,000 runners are due to take part in the London Marathon, but are those 26.2 miles doing us harm?

Alfie Evans case: Supreme Court rules against parents for second time

The court has also refused permission for the parents of the terminally ill toddler to appeal.

Medic suspended over Tipton mother's sepsis death

An internal investigation will take place at Russells Hall Hospital after Natalie Billingham's death

London Marathon: How to run in the heat

This London Marathon may break the record for the hottest yet, so how do you run in the heat?

'World's worst' super-gonorrhoea man cured

The patient had a lucky escape say doctors, but now two more cases have been discovered.

Scientists discover mechanism behind motor neurone disease

An international team found that a protein causes brain cells to die when it is stuck in the jelly phase.

Bedford Hospital nurse struck off for 'squeezing' patient's breasts

Gbadebo Olasunkanmi Alabi said "Everything on your body is perfect" to the patient.

Ex-MP Tessa Jowell first to donate data to medical database

Former Culture Secretary Baroness Tessa Jowell hopes better cancer treatments can be developed.

Bajau people 'evolved bigger spleens' for free-diving

In an example of human natural selection, Asia's Bajau people have evolved bigger spleens for diving.

Hospitals recruit managers faster than doctors and nurses

Three quarters of NHS hospital trusts are employing more managers than they did five years ago.

Skin implant could help warn of cancer, scientists say

It works by detecting elevated levels of calcium in the blood linked to some cancers.

Being a patient 'a full-time job'

Rising numbers of people have multiple health conditions, leading to endless appointments and check-ups.

Hans Asperger 'collaborated with Nazis' in WWII

A medical journal suggests the renowned autism paediatrician was a Nazi collaborator.

Mental health patients want immediate diagnosis, says report

Research suggests patients would prefer to be told their diagnosis face-to-face.

Thalassaemia gene therapy trial shows 'encouraging' results

The treatment meant some patients stopped needing blood transfusions altogether.

'My teacher saved me from suicide'

Now 26, Hati Sparey-South is herself training as a teacher, determined to help today's pupils.

Keeping livers 'alive' boosts transplant success, trial finds

The alternative to ice involves pumping livers with blood, nutrients and medicines while in a machine.

Music

Loading…

Badge

Loading…

© 2018   Created by TheArtiste Hassan.   Powered by

Badges  |  Report an Issue  |  Terms of Service